TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
IBIO

iBio, Inc.

Healthcare · Biotechnology

1.10$ -0.4% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow IBIO
Line item 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
– – – – – – – – – – – – – – – – – – – –
– -23.8% +15.8% +18.7% +11.8% -12.5% +2.5% +6.8% +0.6% +159.0% +78.3% +2.0% +2.3% +28.1% +7.7% +57.0% -63.6% -9.4% -76.7% -69.8%
– – – +1,001.4% +1,842.4% -4.0% -52.9% -14.9% -15.0% +36.2% -18.9% -23.8% -68.7% +61.0% +308.8% +176.0% +0.3% -53.6% -24.9% -10.3%
– – – – – – – +51.7% -15.0% -60.0% +162.3% -17.7% -49.5% -7.6% +385.3% +201.8% +381.8% – – –
– -64.0% -351.0% – -131.0% – +96.6% -130.2% – -36.2% -21.0% -69.7% +1,551.1% -67.7% -2,473.2% – +81.0% -154.0% – +426.5%
– -64.5% +460.3% -64.2% -83.7% +160.5% -20.4% +32.8% -17.0% -68.4% +2,242.6% -32.3% -8.2% +16.6% +347.3% +42.0% -21.7% -96.3% -92.4% +3,512.5%
– -72.9% +461.9% -64.3% -83.7% +160.5% -20.4% +32.8% -17.0% -68.4% +2,242.6% -32.3% -8.2% +16.6% +2,194.5% -80.6% – -87.1% -18.1% -4,412.5%
– – – – – – – – – – – – – – – – – – – –
– – – – – – -57.6% -7.4% +206.0% -33.5% -100.0% – +27.2% +25,562.3% – – – -82.1% -100.0% –
– – – – – – – – +0.0% +0.0% -69.9% +7.6% +7.7% +641.6% -77.3% +1,661.3% +56.5% -87.5% -38.9% –
– -25.4% +224.4% -40.0% +163.4% +22.7% -57.6% -7.4% +206.0% +99.4% -100.8% – -84.6% +1,788.0% +20.9% -107.4% – +964.5% -63.5% +1,054.1%
– -98.8% +607,185.1% -112.7% – +43.8% -143.5% – – +129.0% -210.4% – -246.7% – -56.0% -345.5% – – -182.3% –
– – – – – – – – – – – – – – – – – – – –

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?